Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria

Transfusion

Volumn 45, Issue 2, 2005, Pages 208-213

  Eichbaum, Quentin G ^a   Dzik, Walter H ^b   Chung, Raymond T ^b   Szczepiorkowski, Zbigniew M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; BETA CAROTENE; BILIRUBIN; COLESTYRAMINE; ERYTHROCYTE PROTOPORPHYRIN; HEMATIN; PREDNISONE; TACROLIMUS; URSODEOXYCHOLIC ACID;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD TRANSFUSION REACTION; CASE REPORT; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIC PROTOPORPHYRIA; EXCHANGE BLOOD TRANSFUSION; FATIGUE; FEMALE; FEVER; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTERMETHOD COMPARISON; LABORATORY TEST; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALAISE; MALE; PHOTOSENSITIVITY; PLASMAPHERESIS; RECURRENT DISEASE; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ERYTHROCYTE TRANSFUSION; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HEMIN; HUMANS; MALE; MIDDLE AGED; PLASMAPHERESIS; PROTOPORPHYRIA, ERYTHROPOIETIC; PROTOPORPHYRINS; SEVERITY OF ILLNESS INDEX;

EID: 13144280879     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.04190.x     Document Type: Article

References (22)

1. Bottomley S, Tanaka M, Everett M. Diminished erythroid ferrochelatase activity in protoporphyria. J Lab Clin Med 1975;86:126.
2. Rank J, Carithers R, Bloomer J. Evidence for neurological dysfunction in end-stage protoporphyric liver disease. Hepatology 1993;18:1404.
3. Bloomer JR, Phillips MJ, Davidson DL, Klatskin G, Bloomer. Hepatic disease in erythropoietic protoporphyria. Am J Med 1975;58:869.
4. Sassa S, Kappas A. Molecular aspects of the inherited porphyrias. J Intern Med 2000;247:169.
5. Murphy GM. Diagnosis and management of the erythropoietic porphyrias. Dermatol Ther 2003;16:57-64.
6. Doss M, Frank M. Hepatobiliary implications and complications in protoporphyrins: a 20 year study. Clin Biochem 1989;22:223.
7. Dellon ES, Szczepiorkowski ZM, Dzik WH, et al. Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation 2002;73:911-5.
8. Reichheld JH, Katz E, Banner BF, et al. The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria. Transplantation 1999;67:922-8.
9. Pawliuk R, Bachelot T, Wise RJ, et al. Long-term cure of the photosensitivity in murin erythropoietic protoporphyria by preselective gene therapy. Nat Med 1999;5:768-72.
10. Richard E, Geronimi F, Lalanne M, et al. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines. J Gene Med 2003;5:737-47.
11. Do KD, Banner BF, Katz E, Szymanski IO, Bonkovsky HL. Benefits of chronic plasmapheresis and intravenous hemealbumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation 2002;73:469-72.
12. Sil S, Chakraborti AS. Comparative studies on the interaction of protoporphyrin with hemoglobin and myoglobin. Indian J Biochem Biophys 1996;33:285-91.
13. Donaldson E, Donaldson A, Rimington C. Erythropoietic protoporphyria: a family study. Br Med J 1967;1:659-63.
14. Bloomer J. Pathogenesis and therapy of liver disease in protoporphyria. Yale J Biol Med 1979;52:39-48.
15. van Hattum J, Baart de la Faille H, Van den Berg JW, Edixhoven-Bosdijk A, Wilson JH. Chenodeoxycholic acid therapy in erythropoietic protoporphyria. J Hepatol 1986;3:407-12.
16. Todd DJ, Callender ME, Mayne EE, Walsh M, Burrows D. Erythropoietic protoporphyria, transfusion therapy and liver disease. Br J Dermatol 1992;127:534-7.
17. Mathews-Roth M. Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Biochimie 1986;68:875-84.
18. van Wijk HJ, van Hattum J, Baart de la Faille H, et al. Blood exchange and transfusion therapy for acute cholestasis in protoporphyria. Dig Dis Sci 1988;33:1621-5.
19. Bechtel M, Bertelone S, Hodge S. Transfusion therapy in a patient with erythropoietic protoporphyria. Arch Dermatol 1981;117:99-101.
20. Spiva D, Lewsi C. Erythropoietic protoporphyria: therapeutic response to combined erythrocyte exchange and plasmapheresis. Photodermatology 1984;1:211-20.
21. Dobozy A, Csato M, Siklosi C, Simon N. Transfusion therapy for erythropoietic protoporphyria. Br J Dermatol 1983;109:571-6.
22. van Steveninck J, Dubbelman TM, de Goeij AF, Went LN. Binding of protoporphyrin to hemoglobin in red blood cells of patients with erythropoietic protoporphyria. Hemoglobin 1977;1:679-90.